Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Patient-reported outcomes of caries prophylaxis among Swedish caries active adults in a long-term perspective.

Flink H, Tegelberg Å, Arnetz J, Birkhed D.

Swed Dent J. 2016;40(1):101-10.

PMID:
27464386
2.

Antibacterial gauzes are effective in preventing infections after percutaneous endoscopic gastrostomy placement: a retrospective analysis.

Strijbos D, Schoon EJ, Curvers W, Friederich P, Flink HJ, Stronkhorst A, Gilissen LP.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):297-304. doi: 10.1097/MEG.0000000000000561.

PMID:
26735159
3.

Socioeconomic differences in self-rated oral health and dental care utilisation after the dental care reform in 2008 in Sweden.

Molarius A, Engström S, Flink H, Simonsson B, Tegelberg A.

BMC Oral Health. 2014 Nov 18;14:134. doi: 10.1186/1472-6831-14-134.

4.

Dentist and practice characteristics associated with restorative treatment of enamel caries in permanent teeth: multiple-regression modeling of observational clinical data from the National Dental PBRN.

Fellows JL, Gordan VV, Gilbert GH, Rindal DB, Qvist V, Litaker MS, Benjamin P, Flink H, Pihlstrom DJ, Johnson N; National Dental PBRN Collaborative Group..

Am J Dent. 2014 Apr;27(2):91-9.

5.

Concordance between patient satisfaction and the dentist's view: findings from The National Dental Practice-Based Research Network.

Riley JL 3rd, Gordan VV, Hudak-Boss SE, Fellows JL, Rindal DB, Gilbert GH; National Dental Practice-Based Research Network Collaborative Group..

J Am Dent Assoc. 2014 Apr;145(4):355-62. doi: 10.14219/jada.2013.32.

6.

Correlation between perceived experience of caries disease and recorded caries activity among adult patients at a Swedish Public Dental Clinic: A longitudinal study.

Flink H, Tegelberg A, Arnetz J, Birkhed D.

Acta Odontol Scand. 2013 Nov;71(6):1486-92. doi: 10.3109/00016357.2013.771406.

PMID:
23638806
7.

Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.

Sonneveld MJ, Zoutendijk R, Flink HJ, Zwang L, Hansen BE, Janssen HL.

Clin Infect Dis. 2013 Jan;56(1):100-5. doi: 10.1093/cid/cis859.

8.

Complicated systemic lupus erythematosus pancreatitis: pseudocyst, pseudoaneurysm, but real bleeding.

Hoorn EJ, Flink HJ, Kuipers EJ, Poley JW, Mensink PB, Dolhain RJ.

Lupus. 2011 Mar;20(3):305-7. doi: 10.1177/0961203310383071.

PMID:
20956462
9.

Preferences for caries prevention agents in adult patients: findings from the dental practice-based research network.

Riley JL 3rd, Gordan VV, Rindal DB, Fellows JL, Ajmo CT, Amundson C, Anderson GA, Gilbert GH; Dental PBRN Collaborative Group..

Community Dent Oral Epidemiol. 2010 Aug;38(4):360-70. doi: 10.1111/j.1600-0528.2010.00547.x.

10.

General practitioners' use of caries-preventive agents in adult patients versus pediatric patients: findings from the dental practice-based research network.

Riley JL 3rd, Gordan VV, Rindal DB, Fellows JL, Williams OD, Ritchie LK Jr, Gilbert GH; Dental Practice-Based Research Network Collaborative Group..

J Am Dent Assoc. 2010 Jun;141(6):679-87.

11.

Practices participating in a dental PBRN have substantial and advantageous diversity even though as a group they have much in common with dentists at large.

Makhija SK, Gilbert GH, Rindal DB, Benjamin P, Richman JS, Pihlstrom DJ, Qvist V; DPBRN Collaborative Group..

BMC Oral Health. 2009 Oct 15;9:26. doi: 10.1186/1472-6831-9-26.

12.

Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.

Buster EH, Flink HJ, Simsek H, Heathcote EJ, Sharmila S, Kitis GE, Gerken G, Buti M, de Vries RA, Verhey E, Hansen BE, Janssen HL.

Am J Gastroenterol. 2009 Oct;104(10):2449-57. doi: 10.1038/ajg.2009.371.

PMID:
19584831
13.

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.

Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL.

Gastroenterology. 2008 Aug;135(2):459-67. doi: 10.1053/j.gastro.2008.05.031.

PMID:
18585385
14.

Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults.

Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlöf F.

Community Dent Oral Epidemiol. 2008 Dec;36(6):523-31. doi: 10.1111/j.1600-0528.2008.00432.x.

PMID:
18422708
15.
16.

Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.

Flink HJ, Buster EH, Merican I, Nevens F, Kitis G, Cianciara J, de Vries RA, Hansen BE, Schalm SW, Janssen HL.

Gut. 2007 Oct;56(10):1485-6. No abstract available.

17.

Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine.

Flink HJ, Hansen BE, Heathcote EJ, Feinman SV, Simsek H, Karayalcin S, Mach T, Leemans WF, de Man RA, Verhey E, Schalm SW, Janssen HL; HBV 99-01 Study Group..

Am J Gastroenterol. 2006 Nov;101(11):2523-9.

PMID:
17029610
18.

Effect of oral iron supplementation on unstimulated salivary flow rate: a randomized, double-blind, placebo-controlled trial.

Flink H, Tegelberg A, Thörn M, Lagerlöf F.

J Oral Pathol Med. 2006 Oct;35(9):540-7.

PMID:
16968234
19.

Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.

van Zonneveld M, Zondervan PE, Cakaloglu Y, Simon C, Akarca US, So TM, Flink HJ, de Man RA, Schalm SW, Janssen HL; HBV 99-01 Study Group..

Liver Int. 2006 May;26(4):399-405.

PMID:
16629642
20.

The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.

Leemans WF, Flink HJ, Janssen HL, Niesters HG, Schalm SW, de Man RA.

J Hepatol. 2006 Mar;44(3):507-11.

PMID:
16457904
Items per page

Supplemental Content

Loading ...
Support Center